Table 6.
Changes in Model for End-Stage Liver Disease score in the studied groups before infusion, after 2 weeks and 1, 2, 3, 6, 9 and 12 months
| Study group | Pre-treatment | 1 month | 2 months | 3 months | 6 months | 9 months | 12 months |
|---|---|---|---|---|---|---|---|
| Control group | 17.20 ± 1.32 | 16.13 ± 1.54 | 16.47 ± 1.43 | 17.00 ± 1.68 | 17.24 ± 1.90 | 17.15 ± 1.95 | 16.32 ± 3.70 |
| Single infusion | 17.60 ± 1.90 | 15.73 ± 2.89 | 14.90 ± 3.24* | 14.48 ± 3.11* | 14.64 ± 2.92* | 14.86 ± 2.57* | 14.96 ± 2.39* |
| Double infusion | 17.23 ± 1.33 | 15.53 ± 1.99 | 15.03 ± 1.81* | 14.57 ± 1.56* | 14.07 ± 1.72* | 13.97 ± 1.74*# | 13.96 ± 1.59*# |
Data presented as mean ± standard deviation
* P <0.05 between single infusion or repeated infusion and control groups
# P <0.05 between single-infusion and repeated-infusion groups